Pain medicine

Posterior quadratus lumborum block versus epidural analgesia for postoperative pain management after open radical cystectomy: A randomized clinical trial

Acta Anaesthesiol ScandPublished Randomised controlled trial

Authors' conclusion

Opioid consumption did not differ significantly between posterior QLB and an epidural infusion with ropivacaine for the first 2 postoperative days following RC.

Study context

Population
Adults aged 18–85 with bladder cancer scheduled for open radical cystectomyincluded in the analyses
Participants
20 vs 19
Comparison
Posterior quadratus lumborum block (QLB) vs epidural analgesia
  • QLBn = 20
  • Epidural analgesian = 19reference
Primary endpoint
Cumulative rescue opioid (oxycodone PCA) consumption
Follow-up
POD 0-2

Primary result

As reported in the abstract

Cumulative rescue opioid consumption, POD 0 (9-12 h) · POD 0
GroupValueDoses
QLB14 (interval (unspecified) 7.6–33.3) mg8 (3.6-15.7)
Epidural analgesia6.1 (interval (unspecified) 2.0–16.1) mg4 (1.3-8.5)

Value

QLB14 (interval (unspecified) 7.6–33.3) mg
Epidural analgesia6.1 (interval (unspecified) 2.0–16.1) mg

Doses

QLB8 (3.6-15.7)
Epidural analgesia4 (1.3-8.5)
  • QLB vs Epidural analgesia: P = 0.089 — mg
  • QLB vs Epidural analgesia: P = 0.057 — doses

Secondary outcomes

Cumulative rescue opioid consumption (oxycodone) · POD 1 · mg

P = 0.749

Doses QLB 12 (5.5-23.0) · Epidural analgesia 10 (8-20) · P > 0.9

OutcomeP value
Cumulative rescue opioid consumption (oxycodone) · POD 2mgP = 0.749
Cumulative rescue opioid consumption (oxycodone) · POD 2DosesP > 0.9

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Posterior quadratus lumborum block versus epidural analgesia for postoperative pain management after open radical cystectomy: A randomized clinical trial. Acta Anaesthesiol Scand. Published 3 January 2023. doi:10.1111/aas.14188

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.